Ranbaxy to take human trials for prostrate drug to UK
With the Government yet to take a call on allowing Phase I clinical trials in India, Ranbaxy looks poised to take the human trial for its investigational new drug (IND) in the benign prostrate
With the Government yet to take a call on allowing Phase I clinical trials in India, Ranbaxy looks poised to take the human trial for its investigational new drug (IND) in the benign prostrate